Cancer vaccines are a novel method of preventing and treating cancer by activating the immune system of the body to identify and destroy tumor cells. The seminar "Cancer Vaccines" is centered on recent advances in therapeutic and preventive vaccines intended to target particular cancer antigens.
Unlike classic vaccines that are designed to prevent infectious diseases, cancer vaccines are made to assist the immune system in recognizing abnormal proteins or antigens found on cancer cells. Therapeutic vaccines are designed to treat ongoing cancers by engaging immune responses, while preventive vaccines target declining the risk of virus-induced cancers like the HPV vaccine for cervical cancer.
This session discusses different vaccine development strategies, such as peptide-based vaccines, dendritic cell vaccines, and mRNA-based platforms. It also touches on clinical trials, efficacy, and challenges to inducing robust and durable immune responses. Combination therapies involving cancer vaccines with other treatments, such as immunotherapy or checkpoint inhibitors, are being touted as an effective way to improve treatment.
Participants will learn about the science of cancer vaccines, everyday clinical usage, and cutting-edge research that is leading to new-generation immunotherapies. This session underscores the promise of cancer vaccines in providing new hope for both treatment and prevention, reinventing the future of cancer care."
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
